首页> 外文期刊>海南医科大学学报(英文版) >Distribution and drug resistance of pathogens isolated from 4142 blood cultures
【24h】

Distribution and drug resistance of pathogens isolated from 4142 blood cultures

机译:从4142种血液培养物中分离出的病原体的分布和耐药性

获取原文
获取原文并翻译 | 示例
           

摘要

Objective:To investigate the distribution and drug resistance of pathogens isolated from 4142 blood cultures, and provide a scientific foundation for guiding clinical rational use of antimicrobial agents for bloodstream infections.Methods: Blood cultures obtained from 4142 inpatients and outpatients who were hospitalized from Jan 2015 to Dec 2016. The culture was detected by automatic BACT/ALERT 3D blood culture system of biomerieux. Bacteria isolated from positive blood cultures were further identified, and the drug susceptibility tests were conducted by VITEK-2 Compact automatic microbial analysis system and ATB Expression microbial analysis system. The drug susceptibility results were evaluated according to CLSI 2014 standard. Statistical analysis was performed by using WHONET 5.6 software. Results:A total of 396 unique strains were isolated from 4142 blood cultures, and the positive rate is 9.6%. Among the positive blood cultures, 194 (49.0%) strains were identified as Gram-positive, 185 (46.7%) strains were identified as Gram-negative, and 17(4.3%) strains were identified as fungi. The coagulase-negative Staphylococcus were the most frequently detectable (29.2%), followed by Escherichia coli (18.4%), Klebsiella pneumonia (7.3%), Staphylococcus aureus (5.1%), Acinetobacter baumannii(5.1%), and Enterococcus genera (5.1%). The incidences of methicillin resistant coagulase negative staphylococcus (MRCNS) and methicillin resistant staphylococcus aureus (MRSA) were 81.9% and 50.0% respectively. However, vancomycin resistant staphylococcus and enterococcus were not detected. The prevalence of extended spectrumβ lactamases (ESBLs) in E. coli and K. pneumoniae were 56.2% and 37.9%, respectively. All the E. coli strains were sensitive to amikacin, piperacillin/tazobactam, imipenem and meropenem, and the sensitive rate of K. pneumoniae strains to imipenem and meropenem were 93.1% and 89.7%, respectively.Conclusions MRCNS stains were the most frequently detected pathogens in blood cultures in the present study. The characteristic of drug resistance for the pathogens indicated that monitoring of imipenem and meropenem resistant K. pneumoniae should be underlined to prevent nosocomial outbreak. Fungi bloodstream infections of ward such as ICU and department of hemopathology should be enhanced monitored.
机译:目的:了解4142例血液培养物中病原菌的分布和耐药性,为指导临床合理使用抗菌药物治疗血流感染提供科学依据。方法:2015年1月住院的4142例住院和门诊患者的血培养物。到2016年12月。通过biomerieux的自动BACT / ALERT 3D血液培养系统检测培养物。进一步鉴定了从阳性血液培养物中分离出的细菌,并通过VITEK-2 Compact全自动微生物分析系统和ATB Expression微生物分析系统进行了药敏试验。根据CLSI 2014标准评估药物敏感性结果。使用WHONET 5.6软件进行统计分析。结果:共从4142份血培养物中分离到396株独特菌株,阳性率为9.6%。在阳性血液培养物中,有194(49.0%)株被鉴定为革兰氏阳性,有185(46.7%)株被鉴定为革兰氏阴性,有17(4.3%)株被鉴定为真菌。凝固酶阴性葡萄球菌最常见(29.2%),其次是大肠杆菌(18.4%),肺炎克雷伯菌(7.3%),金黄色葡萄球菌(5.1%),鲍曼不动杆菌(5.1%)和肠球菌属(5.1) %)。耐甲氧西林的凝固酶阴性葡萄球菌(MRCNS)和耐甲氧西林的金黄色葡萄球菌(MRSA)的发生率分别为81.9%和50.0%。但是,未检测到耐万古霉素的葡萄球菌和肠球菌。大肠杆菌和肺炎克雷伯菌中超广谱β内酰胺酶(ESBLs)的患病率分别为56.2%和37.9%。所有大肠杆菌菌株均对阿米卡星,哌拉西林/他唑巴坦,亚胺培南和美罗培南敏感,肺炎克雷伯菌菌株对亚胺培南和美罗培南的敏感率分别为93.1%和89.7%。在本研究中的血液培养中。对病原体的耐药性特征表明,应强调对亚胺培南和美罗培南耐药的肺炎克雷伯菌的监测,以防止医院内暴发。病房如ICU和血液病理科的真菌血流感染应加强监测。

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2018年第5期|1-5|共5页
  • 作者单位

    The Medical Laboratory Center, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, 410007, China;

    The Medical Laboratory Center, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, 410007, China;

    The Medical Laboratory Center, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, 410007, China;

    The Medical Laboratory Center, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, 410007, China;

    The Medical Laboratory Center, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, 410007, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号